The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Methods Of Using Sustained Release Aminopyridine Compositions - EP2377536

The patent EP2377536 was granted to Acorda Therapeutics on Aug 17, 2022. The application was originally filed on Apr 11, 2005 under application number EP11160247A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2377536

ACORDA THERAPEUTICS
Application Number
EP11160247A
Filing Date
Apr 11, 2005
Status
Patent Maintained As Amended
Jul 15, 2022
Publication Date
Aug 17, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

NEURAXPHARM ARZNEIMITTELDec 6, 2013KONIGERADMISSIBLE
SYNTHONDec 6, 2013PRINSADMISSIBLE
ACTAVIS GROUP PTC EHFDec 5, 2013ELKINGTON AND FIFEADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20040010828
DESCRIPTIONUS20040560894
DESCRIPTIONUS2004008101
DESCRIPTIONUS5952357
SEARCHIE82916

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents